Ironwood Pharmaceuticals | IRWD - Pre Tax Profit


Ironwood Pharmaceuticals reported $68.02M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 26.32M 18.28M Dec/2025
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Almirall EUR 30.32M 22M Dec/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Amarin USD -852K 7.26M Dec/2025
Ardelyx USD -400K 467K Dec/2025
Astellas Pharma JPY 133.96B 29.77B Dec/2025
AstraZeneca USD 3.24B 117M Sep/2025
Charles River Laboratories USD 170.03M 98.62M Sep/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Lexicon Pharmaceuticals USD -12.77M 16.02M Sep/2025
MacroGenics USD -14.93M 31.75M Dec/2025
Moderna USD -187M 631M Sep/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
Pacira USD 9.52M 11.45M Sep/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
Takeda JPY 133.86B 105.69B Dec/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vanda Pharmaceuticals USD -22.92M 16.68M Dec/2024